Happenings Archive

What's Happening Now is a quick, thoughtful, real-time briefing regarding material events in the stem cell industry...definitely not the usual stream of insignificant press releases. The most current Happenings are boxed on the left-hand side of most pages on this site. Feel free to use this page to explore the archive of all past Happening items, and subscribe to the RSS feed to stay on top of the events that move the market and the industry.


Aastrom Announces Reverse Stock Split, Shares Plunge
Oct 11, 2013
Following a trend increasingly common among wilting stem cell penny stocks, Aastrom (ASTM) announced a 1-for-20 reverse stock split intended to hike its share price above $1 to meet NASDAQ's listing requirements. At the opening bell this morning ASTM dropped 23% on the news.
Aastrom Offers New Shares; Price Plummets
Aug 14, 2013
In a move that will more than double its shares outstanding, Aastrom (ASTM) announced a new share offering, triggering a massive sell-off that depressed the share price 43%. The new offer will raise roughly $8 million for the beleaguered company, leaving it $12 million in cash (about half a year of runway, with the completion of its only current clinical trial still two years away).
Aastrom trial shows continuing signs of life
Jul 20, 2013
Following a brutal first half FY (which witnessed a going-concern warning, management shakeup, layoffs, trial termination, and ever-declining share price), Aastrom (ASTM) notched some modestly encouraging news with the latest update to its heart failure clinical trial record, recruiting 4 new sites last month (for a total of 35), suggesting the company's hopes are still alive.
Aastrom (ASTM) Files Highly Dilutive Shelf Registration
May 1, 2013
With less than a year of cash on hand and on the heels of its recent 50% reduction in force and clinical trial termination, Aastrom (ASTM) has filed a shelf registration for the issuance of up to $25M in new shares (a figure roughly equaling its current market cap). Its shares closed 13% off for the day.
Aastrom (ASTM) Axes Trial, Announces Layoffs
Mar 27, 2013
Chronically cash-strapped Aastrom Biosciences (ASTM) announced the termination of its Phase 3 critical limb ischemia trial and the layoff of half its workforce. At market open its shares plunged more than 30%.
Aastrom Biosciences (ASTM) Operating Under a 'Going Concern' Warning
Mar 19, 2013
Aastrom Biosciences' (ASTM) FY12 annual report, filed yesterday with the SEC, revealed that the company has received a 'going concern' warning from its independent accounting firm.
Bad News For Aastrom (ASTM)
Mar 12, 2013
Aastrom Biosciences (ASTM) is the only SCSI component company to make Bloomberg BusinessWeek's list of Largest Nasdaq Short Interest Percent Increases for February, indicating a substantial increase in bets against the company's future share price performance.
< Previous Page  |  Next Page >